ID: ALA86205

Max Phase: Preclinical

Molecular Formula: C17H19N3O2S

Molecular Weight: 329.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)C(Cc1ccccc1)/N=C(\S)Nc1ccccn1

Standard InChI:  InChI=1S/C17H19N3O2S/c1-2-22-16(21)14(12-13-8-4-3-5-9-13)19-17(23)20-15-10-6-7-11-18-15/h3-11,14H,2,12H2,1H3,(H2,18,19,20,23)

Standard InChI Key:  UVKOFACZWXQGNK-UHFFFAOYSA-N

Associated Targets(non-human)

Glucose-6-phosphatase 38 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 329.43Molecular Weight (Monoisotopic): 329.1198AlogP: 2.95#Rotatable Bonds: 6
Polar Surface Area: 63.58Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.81CX Basic pKa: 4.27CX LogP: 4.02CX LogD: 3.44
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.37Np Likeness Score: -0.81

References

1. Farhanullah, Sil D, Tripathi BK, Srivastava AK, Ram VJ..  (2004)  Synthesis and glucose-6-phosphatase inhibitory activity of (thiouriedo)alkanoic acid esters.,  14  (10): [PMID:15109654] [10.1016/j.bmcl.2004.02.079]

Source